Browse studies

Find your next paid study

7 recruiting studies matching your filters

Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter Pylori Neutrophil-Activating Protein (NAP) (MV-s-NAP) in Patients With Metastatic Breast Cancer

This phase I trial investigates the side effects and best dose of using a modified measles virus, MV-s-NAP, in treating patients with invasive breast cancer th…

Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast CarcinomaMetastatic Breast Adenocarcinoma+2 more

Estimated

~$10 – $6,250

Mayo ClinicNCT04521764

Observational

Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC)

This clinical trial studies whether a healthy living intervention (HLI), with or without a physical activity intervention (PAI), helps maintain the ability to …

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more

Estimated

~$10 – $6,250

Wake Forest University Health SciencesNCT07474090

Phase 2

A Phase II Pilot Study of (Lutetium (177Lu)-DOTATATE in Patients With Metastatic Breast Cancer

This phase II trial investigates how well 177Lu-DOTATATE works in treating patients with breast cancer that is stage IV or has come back (recurrent). 177Lu-DOT…

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaRecurrent Breast Carcinoma

Estimated

~$10 – $7,500

OHSU Knight Cancer InstituteNCT04529044

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

This study is being done to create a resource of samples and information that can be used to improve our understanding of the development, progression and trea…

Breast CarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma

Estimated

~$10 – $750

Mayo ClinicNCT06217874

Phase 2

I-CURE-1: A Phase II, Single Arm Study of Pembroluzimab Combined With Carboplatin in Patients With Circulating Tumor Cells (CTCs) Positive Her-2 Negative Metastatic Breast Cancer (MBC)

The purpose of the study is to evaluate the impact on progression-free survival (PFS) with the combination carboplatin - pembrolizumab in patients with CTC (ci…

Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more

Estimated

~$10 – $6,250

Northwestern UniversityNCT03213041

Phase 1

Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Triple Negative Breast Cancer (TNBC)

This phase I trial tests the safety, side effects, and best dose of a personalized vaccine (tumor membrane vesicle or TMV vaccine) by itself and in combination…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more

Estimated

Phase 3

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. …

CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more

Estimated

~$10 – $7,500

SWOG Cancer Research NetworkNCT03418961